4DMedical (ASX:4DX)Melbourne-based respiratory imaging technology company has signed a contract with Perth Radiological Clinic (PRC) to deploy its XV Technology-enabled ventilation reports across 16 clinics in Perth.
XV Technology dynamically measures and displays airflow in the lungs, allowing doctors to detect respiratory deficiencies earlier and with greater sensitivity. By providing detailed, region-specific data on lung function, the technology offers unprecedented diagnostic insights compared to conventional imaging methods. XV Technology powers 4DMedical’s FDA-cleared XV Lung Ventilation Analysis (XV LVAS) software and its CT-enabled counterpart, CT LVAS, which utilizes existing hospital infrastructure.
PRC is a leading provider of diagnostic imaging in Western Australia, serving much of the Perth metropolitan area. The commitment between the two companies was catalyzed by 4DMedical’s presentation at the Royal Australian and New Zealand College of Radiologists (RANZCR) annual scientific meeting, where the clinical benefits of XV Technology received strong support from PRC thoracic radiologists .
Under the agreement, PRC will offer both CT LVAS ventilation reporting via standard computed tomography infrastructure and XV LVAS reporting via fluoroscopy. These advanced diagnostic insights will be delivered under a Software-as-a-Service (SaaS) model, in line with 4DMedical’s other partnerships. The contract will last until September 30, 2025.
4DMedical CEO and founder Professor Andreas Fouras said: “We are delighted to partner with PRC, the leader in diagnostic imaging in Western Australia. This collaboration highlights the value and demand for XV technology in improving respiratory diagnostics. We look forward to supporting the PRC in providing world-class respiratory care to the Perth community.”
4DMedical shares rose 7.61% to 49.5 cents.